DURECT Corporation Announces First Quarter 2020 Financial Results and Update of Programs

Go back to DURECT Corporation Announces First Quarter 2020 Financial Results and Update of Programs

DURECT Corp (DRRX) Misses Q1 EPS by 1c

May 11, 2020 5:03 PM EDT

DURECT Corp (NASDAQ: DRRX) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $2.8 million versus the consensus estimate of $7.19 million.

"We are pleased to be working with the FDA on the design of a double-blind, multi-center,... More